We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
Products / PRODUCT LIST
API products

API PRODUCTS PORTFOLIO

Inke's products are high-added-value active pharmaceutical ingredients (APIs),
mainly for use in respiratory inhalation and CNS therapies
API Indication Micronised CEP EU DMF US DMF JP DMF KR DMF CN DMF
Imidapril Hypertension
Indacaterol maleate p Asthma and COPD
Loratadine p Allergy
Montelukast sodium p Asthma, allergic & seasonal rhinitis
Nitrendipine Hypertension
Olanzapine p Schizophrenia, psychosis
Olanzapine pamoate Schizophrenia, psychosis
Olodaterol p COPD
Otilonium bromide Irritable bowel syndrome
Paliperidone palmitate Schizophrenia, bipolar mania
Pipamparone Schizophrenia
Prasugrel base p Prophylaxis and therapy of thrombosis
Quetiapine hemifumarate p Schizophrenia, psychosis
Revefenacin COPD
Risperidone p Schizophrenia, psychosis
Rivaroxaban Thrombosis. Stroke
Rizatriptan benzoate p Migraine
Salmeterol xinafoate p Asthma and COPD
Tafamidis Transthyretin amyloisosis
Tetrabenazine Parkinson disease
DOWNLOAD INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.


© Neuraxpharm / INKE. All rights reserved.